# Sell Biotech Data to AI Companies | DillisData

URL: https://dillisdata.com/sell-biotech-data-to-ai-companies/

> Sell biotech data to AI companies: lab notebooks, experiment runs with failed results, and trial records you own and never published. Free estimate.

Home / Sell data to AI companies / Sell Biotech Data to AI Companies 

Updated November 15, 2026 

For biotech and life science labs 

## Sell Biotech Data to AI Companies 

Short answer 
Biotech and life sciences labs can license experiment records they own and have not published. Some AI data programs ask for electronic lab notebooks or structured records, with 1,000 or more runs that show inputs and measured outcomes. Failed runs count. Data a sponsor or partner owns does not. 

To sell biotech data to AI companies, most labs grant a license. The license lets a program work from a copy of your experiment records. Your lab keeps the originals and its ownership. Our general guide explains how companies sell data to AI companies in other fields. 

What sets a lab apart is the work that never made it into a paper. Some AI data programs want unpublished runs, and failed runs above all. A journal article shows the win. Your notebook shows the many tries before it, and that is hard to find anywhere else. 

DillisData is a data agency that matches labs with programs that fit. The signing happens between you and the program, and your records go from your systems to theirs. We never hold any of it. We send you no invoice, and programs pay us a referral fee. 

Failed runs count 

Ownership checked first 

Records bypass DillisData 

See what your data is worth 

Progress 

The estimate needs JavaScript. You can also email estimate@dillisdata.com and we'll run it for you. 

 Your details 

## Last step. Where can we reach you? 

Your number and your best matches show up on the next screen. We only use this to help you with your deal. No spam. 

 Full name Add your name. 
 Work email Use your work email, not a personal one. 
 Your job title Choose one Owner or founder CEO or president COO or operations CFO or finance CTO, IT or data lead Legal or compliance Other leadership Choose your job title. 
 Company name Add your company name. 
 Company website Add your company website. 

Optional, but it helps us find the right buyers faster. 

 Phone (optional) 
 Anything we should know? (optional) 

 Leave this empty 
 I make decisions for my company, and DillisData may contact me and introduce my company to data programs. Privacy · Terms 

 Back 
 Show my matches 

 Dillis Data 

Reading your answers 

 0 of 6 programs checked 
 0 of 54 fit factors scored 

Finding your best matches. This takes a few seconds. 

Your records could be worth 

$0 

DillisData's own estimate. It's not an offer or a quote from any program. 

Your best matches from 6 programs, scored on 9 factors 

Program details are our summaries of each program's public information and may change at any time without notice. Each program sets its own terms, eligibility and payouts, and only the agreement you sign with a program is binding. DillisData is not responsible for how a program's terms are worded or for changes a program makes. Some matches shown may have partner links attached to them and may result in compensation to DillisData, this may impact where matches are placed on the page but in no way alters the validity of the result. Terms 
 See the full review of your matches 
 Copy a link to these results 

What programs look for 

## What do AI companies look for in biotech labs? 

Program rules differ, and they can change. Some programs work with labs of about 10 to 1,000 employees, anywhere, that hold several years of experiment archives. Here is what they ask for, and the reason. 

 What some programs ask for Must have or bonus Why they want it 

 Electronic lab notebooks, or ELNs, or structured experiment records your organization owns Must have Dated, structured records show what was tried and in what order. 

 1,000 or more runs with their inputs and measured outcomes Must have A model can link what went in to what came out, across many tries. 

 Failed runs kept alongside the good ones Must have Papers rarely report failures, so this is the rare part. 

 Data that hasn't been published Must have Published work is already out in the world. A program can't get yours elsewhere. 

 Clinical study reports with patient-level data, tables and analysis plans Bonus They show how a trial was planned, run and read. 

 Genomic data collected with research consent Bonus Programs look for the consent as much as the data. 

 In-house assay and analysis tools Bonus An assay is a lab test. Your own tools show how your team measures things. 

 Scientists' write-ups of their experiments Bonus Write-ups capture the reasoning behind each choice. 

Who is not a fit 

## Which labs and records are not a fit? 

Ownership trips up more labs than anything else here. Go through this list before you count your runs. Whatever you exclude gets written into the contract. 

## Data owned by a sponsor or partner 
Work done for a sponsor, or under a collaboration, may belong to someone else. CROs, the contract labs that run studies for clients, need to read this one twice. Read each agreement and any material transfer terms. 

## Data already published 
Some programs rule this out. Your unpublished runs behind a paper may still count, so sort them apart. 

## Device or AI software companies 
If your data is mainly software logs, some programs say this is not a fit. Run records from real experiments are the point. 

## Export-controlled and defense work 
Some programs turn this away. The US Commerce Control List has a category for chemicals, microorganisms and toxins. Ask your lawyer whether your work touches it. 

## Grant-funded work with strings attached 
Grants and government contracts can carry their own terms on data and inventions. Check them before you count those runs as yours. 

## Other companies some programs skip 
Some general programs also pass on staffing agencies and cannabis firms, plus franchisees without control of their own systems. 

Ownership and consent 

## Can a biotech company license data it doesn't fully own? 

Generally, it can license only what it has the right to license. So start with a simple sort. Put your runs into three piles: clearly yours, clearly someone else's, and unsure. Sponsored research agreements, collaborations, licenses from universities and past deals all belong in that review. Your lawyer should look at the unsure pile. Clean ownership matters to programs. 

Keep an eye on what the records give away. A license hands over a copy of your methods and results. So think about your trade secrets, and about any invention you haven't filed on yet. Ask your patent lawyer before those records go in. You choose what is in and what stays out, and that gets written down. 

Human data raises a second set of questions. Research consent forms often say whether data may be reused once identifiers come off ( 45 CFR 46.116 ). Whether that wording reaches a paid AI license is a question for your lawyer and your review board. If a hospital or clinic gave you patient data, its contract may also limit reuse. 

HIPAA may apply as well, if the records came from a covered provider or health plan. HIPAA's test for de-identified data has two methods ( 45 CFR 164.514 ), which HHS explains here . Trial record numbers can count as identifiers under Safe Harbor. Ask a qualified expert how this applies to genomic data, and what to do about it. 

Good lab habits can help you here. FDA's lab rules for nonclinical studies require keeping raw data and protocols in an orderly archive ( 21 CFR 58.190 ). A lab that follows them may already have much of this in shape. This is general information, not legal advice. 

## See what your experiment archive could bring 

Programs often offer $100K to $5M+, largely depending on your lab's size. In a lab, volume and depth of records matter as well. That is a range and never a promise. The estimate gives you a figure for your lab. 

 Estimate my lab's records 

Where it lives 

## Where do your lab records live? 

Most labs keep this across several tools, plus old folders nobody has opened in years. These are common ones. Yours may be different. 

 Record Where it usually lives What to check 

 Experiment notes and protocols ELNs like Benchling , LabArchives or SciNote Can you export with dates and authors kept? 

 Sample and test results LIMS, the lab's sample tracking system, like LabWare Do results link back to the run that made them? 

 Research data across teams Platforms like Dotmatics or IDBS Is the same experiment split across tools? 

 Raw instrument files Instrument computers and network drives Are failed runs still there, or were they purged? 

 Trial documents Clinical folders and vendor systems Who owns them, you or a sponsor? 

 Write-ups and decisions Shared drives, slides, email and chat Do they explain why a project moved on or stopped? 

How it works 

## How does a lab get from archive to signed license? 

Your lawyer's ownership review comes before anything else moves. We stay out of your files throughout. 

 01 

## Take the quiz 

Tell us your size, your systems and how many years of records you hold. There is no upload and no login. 2 minutes 

 02 

## Review your matches 

See your estimate and the programs that fit, plus why each one does. The estimate is not an offer. 

 03 

## Sort what you own 

Your lawyer and lab lead sort runs by ownership, consent and publication status. Then you pick what goes in. 

 04 

## Sign with the program 

The license is between your lab and the program. Records pass directly between you, and the money follows your signed terms. 

Public facts 

## What public numbers say about research data 

These public facts describe other companies, never our own deals. We know of no biotech lab with a public, priced deal for its run records. 

 $110M+ 

Research publisher Wiley's total money from AI deals has passed this mark. Those deals cover published work, which differs from your lab notes. But they show AI firms pay for research content. Wiley 8-K via SEC EDGAR, Jun 2026 

 $75M+ 

Academic publisher Taylor & Francis reported more than this from 2024 data access deals. Much of it came from AI companies. Its owner has called this kind of income non-recurring. Informa 2024 results, Mar 2025 , Informa 2025 results, Mar 2026 

Timing 

## Why should a lab look at this now? 

Nobody can honestly give you a date. These are better reasons to check. 

## Failed runs are unusual to find 
Few people publish what went wrong. Programs tend to pay up for what no one else can supply. 

## Publishing changes the picture 
Some programs want only unpublished data. Once a project comes out in a journal, that part of your archive may no longer qualify. 

## Labs close and archives scatter 
When a project ends or a lab winds down, notebooks and instrument files can be lost. Closed labs can still qualify, if the records survive. 

## Prices may not hold 
A rival holding similar records can cool demand for yours. No one can tell you how long current pricing holds. 

## Check your lab's fit 

The quiz takes two minutes and asks nothing about your science. You will see an estimate and the programs that fit your lab. 

 See my lab's matches 

Questions 

## Questions owners ask 

Do failed experiments really have value? 

Some programs ask for them by name. They want every run, with inputs and outcomes, including ones that failed. A model learns from what didn't work too. Please don't clean these out of your count. 

We don't have 1,000 runs yet. Should we still check? 

That number is what some programs ask for, and rules vary. Other programs look at office records instead, like email, chat and files. Those general programs often want about 50 desk staff, or about 20 or 30 full-time people in others. 

We work with sponsors. Is any of it ours? 

It depends on each agreement. Sponsored work often belongs to the sponsor, and some programs rule that out. Your own internal research may still be yours. Ask your lawyer to sort it project by project. 

Does licensing hurt our patent position? 

It could, depending on what the records reveal and when. We can't answer that for you. Talk to your patent lawyer before any record tied to an unfiled invention goes in. You can leave those projects out. 

Can we include clinical trial data? 

Some programs add value for clinical study reports with patient-level data. But sponsors, consent forms and HIPAA can all limit that. It must be de-identified, and you must own it. Ask your lawyer and your review board first. 

Our lab has shut down. Is it too late? 

Closed or closing companies can qualify, if the records still exist and someone has the right to sign. Check who holds the rights now. A license can't start until that is clear. 

Does DillisData see our science? 

No. We only see your quiz answers. Your notebooks, runs and files never reach us, and we couldn't share them if we wanted to. 

## Keep reading 

 Proprietary Data for AI Training 

 Sell Healthcare Data to AI Companies 

Next step 

## Get an estimate for your lab's records 

A quick quiz gives you a number we keep on the low side, from prices programs have published. Nobody is making an offer yet, and your notebooks stay put. 

 Get my biotech estimate 

Free estimate. Two minutes. No uploads.
